vs

Side-by-side financial comparison of Citi Trends Inc (CTRN) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $197.1M, roughly 1.1× Citi Trends Inc). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs -3.5%, a 22.9% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 10.1%). Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $767.0K). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs -4.3%).

Citi Trends, Inc. is an American retail clothing chain selling discounted products targeted primarily at African-American customers.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

CTRN vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.1× larger
ORGO
$225.6M
$197.1M
CTRN
Growing faster (revenue YoY)
ORGO
ORGO
+68.1% gap
ORGO
78.1%
10.1%
CTRN
Higher net margin
ORGO
ORGO
22.9% more per $
ORGO
19.4%
-3.5%
CTRN
More free cash flow
ORGO
ORGO
$34.0M more FCF
ORGO
$34.8M
$767.0K
CTRN
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
-4.3%
CTRN

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CTRN
CTRN
ORGO
ORGO
Revenue
$197.1M
$225.6M
Net Profit
$-6.9M
$43.7M
Gross Margin
Operating Margin
-3.7%
28.1%
Net Margin
-3.5%
19.4%
Revenue YoY
10.1%
78.1%
Net Profit YoY
3.6%
469.5%
EPS (diluted)
$-0.86
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRN
CTRN
ORGO
ORGO
Q4 25
$197.1M
$225.6M
Q3 25
$190.8M
$150.9M
Q2 25
$201.7M
$101.0M
Q1 25
$211.2M
$86.7M
Q4 24
$179.1M
$126.7M
Q3 24
$176.6M
$115.2M
Q2 24
$186.3M
$130.2M
Q1 24
$215.2M
$110.0M
Net Profit
CTRN
CTRN
ORGO
ORGO
Q4 25
$-6.9M
$43.7M
Q3 25
$3.8M
$21.6M
Q2 25
$871.0K
$-9.4M
Q1 25
$-14.2M
$-18.8M
Q4 24
$-7.2M
$7.7M
Q3 24
$-18.4M
$12.3M
Q2 24
$-3.4M
$-17.0M
Q1 24
$3.6M
$-2.1M
Gross Margin
CTRN
CTRN
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Q1 24
73.9%
Operating Margin
CTRN
CTRN
ORGO
ORGO
Q4 25
-3.7%
28.1%
Q3 25
1.8%
13.7%
Q2 25
0.2%
-12.5%
Q1 25
0.6%
-30.9%
Q4 24
-4.9%
8.1%
Q3 24
-14.1%
5.4%
Q2 24
-3.7%
-10.7%
Q1 24
1.8%
-3.5%
Net Margin
CTRN
CTRN
ORGO
ORGO
Q4 25
-3.5%
19.4%
Q3 25
2.0%
14.3%
Q2 25
0.4%
-9.3%
Q1 25
-6.7%
-21.7%
Q4 24
-4.0%
6.1%
Q3 24
-10.4%
10.7%
Q2 24
-1.8%
-13.1%
Q1 24
1.7%
-1.9%
EPS (diluted)
CTRN
CTRN
ORGO
ORGO
Q4 25
$-0.86
$0.31
Q3 25
$0.46
$0.11
Q2 25
$0.11
$-0.10
Q1 25
$-1.70
$-0.17
Q4 24
$-0.86
$0.05
Q3 24
$-2.21
$0.09
Q2 24
$-0.42
$-0.13
Q1 24
$0.43
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRN
CTRN
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$107.8M
$300.1M
Total Assets
$464.3M
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRN
CTRN
ORGO
ORGO
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Q1 24
$88.6M
Total Debt
CTRN
CTRN
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
CTRN
CTRN
ORGO
ORGO
Q4 25
$107.8M
$300.1M
Q3 25
$113.2M
$255.1M
Q2 25
$108.6M
$233.2M
Q1 25
$113.2M
$242.9M
Q4 24
$130.3M
$262.9M
Q3 24
$136.6M
$278.5M
Q2 24
$154.8M
$263.5M
Q1 24
$157.7M
$278.0M
Total Assets
CTRN
CTRN
ORGO
ORGO
Q4 25
$464.3M
$598.7M
Q3 25
$457.4M
$509.8M
Q2 25
$437.4M
$461.1M
Q1 25
$462.8M
$467.4M
Q4 24
$467.1M
$497.9M
Q3 24
$506.7M
$446.3M
Q2 24
$484.1M
$443.2M
Q1 24
$518.7M
$458.5M
Debt / Equity
CTRN
CTRN
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRN
CTRN
ORGO
ORGO
Operating Cash FlowLast quarter
$8.6M
$39.4M
Free Cash FlowOCF − Capex
$767.0K
$34.8M
FCF MarginFCF / Revenue
0.4%
15.4%
Capex IntensityCapex / Revenue
4.0%
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$11.9M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRN
CTRN
ORGO
ORGO
Q4 25
$8.6M
$39.4M
Q3 25
$3.9M
$3.1M
Q2 25
$-11.0M
$-32.9M
Q1 25
$28.5M
$-19.9M
Q4 24
$-18.4M
$10.9M
Q3 24
$5.6M
$8.7M
Q2 24
$-19.6M
$4.7M
Q1 24
$23.3M
$-10.2M
Free Cash Flow
CTRN
CTRN
ORGO
ORGO
Q4 25
$767.0K
$34.8M
Q3 25
$-1.7M
$844.0K
Q2 25
$-13.1M
$-36.5M
Q1 25
$26.0M
$-23.6M
Q4 24
$-20.4M
$7.6M
Q3 24
$1.7M
$6.1M
Q2 24
$-21.2M
$2.9M
Q1 24
$20.0M
$-12.4M
FCF Margin
CTRN
CTRN
ORGO
ORGO
Q4 25
0.4%
15.4%
Q3 25
-0.9%
0.6%
Q2 25
-6.5%
-36.1%
Q1 25
12.3%
-27.2%
Q4 24
-11.4%
6.0%
Q3 24
0.9%
5.3%
Q2 24
-11.4%
2.2%
Q1 24
9.3%
-11.3%
Capex Intensity
CTRN
CTRN
ORGO
ORGO
Q4 25
4.0%
2.1%
Q3 25
2.9%
1.5%
Q2 25
1.0%
3.6%
Q1 25
1.2%
4.2%
Q4 24
1.1%
2.7%
Q3 24
2.2%
2.2%
Q2 24
0.9%
1.4%
Q1 24
1.5%
2.0%
Cash Conversion
CTRN
CTRN
ORGO
ORGO
Q4 25
0.90×
Q3 25
1.01×
0.14×
Q2 25
-12.59×
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24
Q1 24
6.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons